The carrier clinic: an evaluation of a novel clinic dedicated to the follow-up of <i>BRCA1</i> and <i>BRCA2</i> carriers—implications for oncogenetics practice

Abstract

A novel specialist clinic for BRCA1/2 mutation carriers has been successfully established. The number of mutation positive families is increasing. This, and the high demand for RRBSO in women over 40, is inevitably going to place an increasing demand on existing health resources. Our clinic model has subsequently been adopted in other centres and this will greatly facilitate translational studies and provide a healthcare structure for management and follow-up of such people who are at a high cancer risk.